VIVE Vivesto AB (publ)

0.7136USD7.250 SEK · STO+1.54%Mkt Cap: 7.90M USDP/E: —

Vivesto AB (publ) develops, develops, markets, and sells drugs in the field of human and veterinary oncology in Sweden. Its lead product, Paccal Vet, is a formulation of paclitaxel with its XR-17 encapsulation technology…